Provided by Tiger Trade Technology Pte. Ltd.

CRISPR Therapeutics AG

55.72
-1.0400-1.83%
Post-market: 55.50-0.2200-0.39%19:59 EDT
Volume:1.71M
Turnover:95.24M
Market Cap:5.35B
PE:-8.61
High:57.24
Open:56.84
Low:54.57
Close:56.76
52wk High:78.48
52wk Low:33.03
Shares:95.99M
Float Shares:90.53M
Volume Ratio:1.08
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4700
EPS(LYR):-6.4700
ROE:-30.18%
ROA:-15.76%
PB:2.78
PE(LYR):-8.61

Loading ...

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

GlobeNewswire
·
Yesterday

Agilent Technologies (A) Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch

Simply Wall St.
·
Apr 15

Reaffirming Buy on CRISPR Therapeutics: Conference Engagement and Gene-Editing Leadership Support Attractive Risk‑Reward

TIPRANKS
·
Apr 14

This Nuclear Stock Had Its Best Day Ever. Cathie Wood's ARK Took the Moment to Sell. -- Barrons.com

Dow Jones
·
Apr 11

Is CRISPR Therapeutics (CRSP) Pricing Reflect Its Sharp Five‑Year Share Price Pullback

Simply Wall St.
·
Apr 09

CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
Apr 07

Assessing CRISPR Therapeutics (CRSP) Valuation As Casgevy Revenue And Cash Position Support Its Growth Transition

Simply Wall St.
·
Apr 04

CRISPR Therapeutics announces annual shareholder meeting, releases preliminary proxy statement

Reuters
·
Apr 03

Is CRISPR Therapeutics (CRSP) Pricing Look Attractive After Recent Share Price Weakness

Simply Wall St.
·
Mar 29

USPTO Ruling Impacts Editas Medicine CRISPR IP Position

TIPRANKS
·
Mar 27

CRISPR Therapeutics Ag : Leerink Partners Cuts Target Price to $60 From $74

THOMSON REUTERS
·
Mar 25

Is CRISPR Therapeutics (CRSP) Attractive After Recent Share Price Weakness And DCF Upside?

Simply Wall St.
·
Mar 22

Crispr Therapeutics Completes $600 Million Convertible Notes Offering

TIPRANKS
·
Mar 17

CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story

Simply Wall St.
·
Mar 14

Press Release: Morningstar, Inc. Declares Quarterly Dividend of 50 Cents Per Share

Dow Jones
·
Mar 14

Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS

TIPRANKS
·
Mar 13

CRSP, SOLQ: Cathie Wood’s ARK ‘Buys the Dip’ in CRISPR and Solana Staking ETF

TIPRANKS
·
Mar 11

Crispr Therapeutics prices upsized convertible senior notes offering

TIPRANKS
·
Mar 11

Cathie Wood’s ARK Investment buys 281K shares of Crispr Therapeutics today

TIPRANKS
·
Mar 11

What's Going On With CRISPR Therapeutics Stock Today?

Benzinga_recent_news
·
Mar 11